Fig. 3From: Genetic and RNA-related molecular markers of trastuzumab-chemotherapy-associated cardiotoxicity in HER2 positive breast cancer: a systematic reviewOverview of the genetic determinants of CTRCT in HER2+ breast cancer patientsBack to article page